CYP2D6 gene polymorphic markers role in determining the optimal treatment tactics for portal hypertension in patients with liver cirrhosis

Aim. To study the polymorphic markers CYP2D6*4 (G1846A, rs3892097), CYP2D6*6 (T1707del, rs5030655), CYP2D6*10 (C100T, rs1065852), CYP2D6*41 (G2988A, rs28371725) and CYP2D6*3 (A2549del, rs4986774) role in treatment optimization of portal hypertension with propranolol in patients with liver cirrhosis...

Full description

Bibliographic Details

Published in:	Terapevtic̆eskii arhiv Vol. 94; no. 2; pp. 200 - 208
Main Authors:	Sychev, Dmitry A., Parusov, Andrei I., Loranskaya, Irina D., Denisenko, Natalia P., Akmalova, Kristina A., Sozaeva, Zhannet A., Turkina, Olga L., Zastrozhin, Michael S.
Format:	Journal Article
Language:	English Russian
Published:	"Consilium Medicum" Publishing house 15-02-2022
Subjects:	cyp2d6 liver cirrhosis pharmacogenetics portal hypertension propranolol
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!